Voglow GM 1 Forte Tablet SR
By Voglow GM
Rx
15 Tablet SR in a Strip

Composition
Glimepiride(1mg) + Metformin(1000mg) + Voglibose(0.2mg)

Manufacturer - Primus Remedies Pvt Ltd
Primus Remedies Pvt Ltd, C-16, Ankur Cooperative Society, Thakurli Estate, Dombivili, Mumbai-421202.

Expires on or after
July, 2025

liver
Caution should be taken when using Voglow GM 1 Forte Tablet SR in patients with liver disease. It may be necessary to adjust the dosage of this medication, so consulting your doctor is important. For individuals with mild to moderate liver disease, it is advisable to initiate Voglow GM 1 Forte Tablet SR at a low dose. However, this medication is not recommended for patients with severe liver disease. If you have liver issues, please seek guidance from your healthcare provider before starting Voglow GM 1 Forte Tablet SR.

kidney
Voglow GM 1 Forte Tablet SR may not be safe for individuals with kidney disease. It is advised to avoid using this medication if you have kidney issues. Consult your doctor regarding its usage, especially if you have severe kidney disease.

alcohol
It is not safe to drink alcohol while taking Voglow GM 1 Forte Tablet SR.

driving
For safety while driving, be cautious if you experience low or high blood sugar symptoms as they can impair your ability to drive. Avoid driving in such instances.

pregnancy
During pregnancy, it is advised to be cautious while using Voglow GM 1 Forte Tablet SR as it may not be safe. Animal studies suggest potential harm to the developing baby. Your doctor will evaluate the risks versus benefits before recommending this medication. Please consult your doctor for guidance.

breastfeeding
Voglow GM 1 Forte Tablet SR is likely unsafe for breastfeeding. Limited data showed it can pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹212.85
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024